We investigated the expression of intercellular adhesion molecule 1 (I
CAM-1) in ex vivo human hepatocellular carcinoma (HCC) cells and in vi
tro in eight liver cancer cell lines, including six HCC cell lines and
two combined hepatocholangiocarcinoma (CHC) cell Lines. Immunohistoch
emistry showed the expression of ICAM-1 on the HCC cell surface with h
oneycomblike appearance in most cases (96.2%), On the other hand, hepa
tocytes in noncancerous areas did not express ICAM-1, except those hep
atocytes in the periportal and intra-acinar areas with inflammation. I
mmunohistochemical study on cultured cells revealed that four cultured
HCC cell lines and one CHC cell line constitutively expressed ICAM-1
on the cell surface and in the cytoplasm. Flow cytometric analysis rev
ealed that immunostain-positive cells expressed surface ICAM-1 with mo
re than a 90% positive cell rate, and their expressions were upregulat
ed by incubation of cells with inflammatory cytokines, such as interfe
ron alfa, interferon gamma, tumor necrosis factor-alpha, and interleuk
in 1 beta. Soluble ICAM-1 was detected in supernatants of cell lines e
xpressing cell surface ICAM-1, in addition to one HCC cell line withou
t surface ICAM-1 expression, and was increased in amounts 2- to 20-fol
d by inflammatory cytokines, These findings suggest that liver cancer
cells in ex vivo may express not only surface but also a soluble form
of ICAM-1, differently from normal hepatocytes, and that both expressi
ons are upregulated by inflammatory cytokines.